Axon Enterprise stock has delivered very strong gains over the past five years, yet current valuation checks suggest investors are now paying a rich price relative to an intrinsic value estimate and the broader set of metrics.

• Axon Enterprise has returned 234.4% over the past five years, which puts extra focus on whether today’s price still leaves enough room for long term returns to match that history.
• The company’s recurring revenue model and focus on public safety software can support long term cash generation, but valuation could be sensitive if growth in contracted revenue or cash flow timing falls short of expectations.
• The stock screens as expensive on the intrinsic value estimate, with the Discounted Cash Flow (DCF) model sitting about 37.5% below the recent share price. The broader checks are mixed, and Axon Enterprise is only undervalued in 2 of 6 valuation tests, which points to a stock that currently leans expensive rather than a clear bargain.

The issue now is whether Axon Enterprise’s cash flow potential and business quality are strong enough to justify paying a premium to this intrinsic value estimate.

Spot potential alternatives if Axon Enterprise feels fully priced by scanning our hand picked list of 51 high quality undervalued stocks.

Does Axon Enterprise Look Pricey on Cash Flow?

The Discounted Cash Flow (DCF) model takes Axon Enterprise’s projected future cash flows and discounts them back to today’s dollars. Axon Enterprise has reported latest twelve month free cash flow of about $136.8 million, and the model assumes that free cash flow continues growing from that base over the coming decade. Based on those cash flow projections, the DCF model points to an estimated intrinsic value of about $442 per share.

That compares to a current share price that sits about 37.5% above this intrinsic value estimate, so the stock screens as overvalued on this method. The key question for you is whether Axon Enterprise can eventually deliver the level and timing of cash flows that would justify paying this premium to the DCF output.

On this DCF view, Axon Enterprise stock currently screens as overvalued relative to its modeled cash flow value.

Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 37.5%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.

Does Axon Enterprise Look Fairly Valued on Sales?

P/S is a useful cross-check for Axon Enterprise because the company leans heavily on recurring software and services revenue, where sales-based metrics often give a cleaner view than earnings-based ones.

Axon Enterprise currently trades on a P/S of about 15.3x, compared with an Aerospace & Defense industry average of 4.8x and a peer group average of 17.4x. The fair P/S ratio from the model is 15.9x, which is only slightly above the current level. That points to a stock that is priced close to what the model suggests for a business with Axon Enterprise’s profile rather than one that is clearly cheap or stretched on sales.

For investors weighing the rich absolute P/S number, the key question is whether Axon Enterprise’s revenue mix and growth profile justify staying closer to peer levels instead of industry averages, which are pulled down by more hardware-heavy companies.

On the P/S multiple, Axon Enterprise looks roughly fairly valued relative to its modeled fair ratio and peers.

The Axon Enterprise Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Axon Enterprise valuation checks leave off. They explain which potential paths for Axon Enterprise's growth, margins and earnings would need to occur for the stock to be worth meaningfully more or less than today’s price. Each narrative links a fair value to a specific story about the company’s potential catalysts and risks, so you can monitor which scenario is unfolding on the Community page over time.

Community narratives on Axon Enterprise are far apart, with one side arguing the stock still underprices its public safety platform and another seeing a rich valuation that demands near flawless execution.

Bull case: 12% undervalued

"Fast-track adoption of new Axon products such as Draft One (AI), TASER 10, Axon Body 4, and Dedrone (counter-drone) is driving up average deal values and product bundles per customer…"

Bear case: roughly fairly valued

"This creates meaningful switching costs."

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

The Bottom Line

The Discounted Cash Flow (DCF) view suggests Axon Enterprise trades above its intrinsic value estimate, while the sales multiple points closer to a stock that is reasonably in line with its peers. Taken together, the broader checks lean more toward expensive than cheap, even if not at an extreme. From here, the real swing factor is whether Axon Enterprise can sustain the revenue growth and cash flow progression implied by today’s pricing, without material disappointment in contracted revenue or cash conversion timing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.